OBIZ SA (ALBIZ.PA) Fundamental Analysis & Valuation

EPA:ALBIZ • FR0014003711

Current stock price

2.66 EUR
-0.18 (-6.34%)
Last:

This ALBIZ.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALBIZ.PA Profitability Analysis

1.1 Basic Checks

  • ALBIZ had negative earnings in the past year.
  • In the past year ALBIZ had a positive cash flow from operations.
  • In multiple years ALBIZ reported negative net income over the last 5 years.
  • Of the past 5 years ALBIZ 4 years had a positive operating cash flow.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

  • ALBIZ has a Return On Assets of -6.75%. This is in the lower half of the industry: ALBIZ underperforms 74.24% of its industry peers.
  • ALBIZ has a Return On Equity of -37.20%. This is in the lower half of the industry: ALBIZ underperforms 72.73% of its industry peers.
Industry RankSector Rank
ROA -6.75%
ROE -37.2%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • ALBIZ has a worse Gross Margin (14.17%) than 81.82% of its industry peers.
  • In the last couple of years the Gross Margin of ALBIZ has declined.
  • ALBIZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALBIZ.PA Health Analysis

2.1 Basic Checks

  • ALBIZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALBIZ has more shares outstanding
  • The number of shares outstanding for ALBIZ has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALBIZ has an improved debt to assets ratio.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 2.50 indicates that ALBIZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ALBIZ has a Altman-Z score of 2.50. This is amongst the best in the industry. ALBIZ outperforms 83.33% of its industry peers.
  • ALBIZ has a Debt/Equity ratio of 2.12. This is a high value indicating a heavy dependency on external financing.
  • ALBIZ has a worse Debt to Equity ratio (2.12) than 71.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF N/A
Altman-Z 2.5
ROIC/WACCN/A
WACC5.62%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

  • ALBIZ has a Current Ratio of 1.73. This is a normal value and indicates that ALBIZ is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBIZ has a better Current ratio (1.73) than 87.88% of its industry peers.
  • A Quick Ratio of 1.26 indicates that ALBIZ should not have too much problems paying its short term obligations.
  • The Quick ratio of ALBIZ (1.26) is better than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.26
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALBIZ.PA Growth Analysis

3.1 Past

  • The earnings per share for ALBIZ have decreased strongly by -693.75% in the last year.
  • The Revenue has been growing slightly by 2.79% in the past year.
  • The Revenue has been growing by 67.67% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-693.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.11%
Revenue 1Y (TTM)2.79%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%-0.44%

3.2 Future

  • Based on estimates for the next years, ALBIZ will show a very strong growth in Earnings Per Share. The EPS will grow by 55.13% on average per year.
  • Based on estimates for the next years, ALBIZ will show a small growth in Revenue. The Revenue will grow by 6.63% on average per year.
EPS Next Y-2673.32%
EPS Next 2Y-158.2%
EPS Next 3Y55.13%
EPS Next 5YN/A
Revenue Next Year-20.87%
Revenue Next 2Y2.37%
Revenue Next 3Y3.43%
Revenue Next 5Y6.63%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALBIZ.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALBIZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALBIZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

  • ALBIZ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALBIZ is more expensive than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.18
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALBIZ's earnings are expected to grow with 55.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-158.2%
EPS Next 3Y55.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALBIZ.PA Dividend Analysis

5.1 Amount

  • No dividends for ALBIZ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBIZ.PA Fundamentals: All Metrics, Ratios and Statistics

OBIZ SA

EPA:ALBIZ (4/8/2026, 7:00:00 PM)

2.66

-0.18 (-6.34%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.41%
Inst Owner ChangeN/A
Ins Owners53.65%
Ins Owner ChangeN/A
Market Cap15.61M
Revenue(TTM)125.62M
Net Income(TTM)-3.72M
Analysts83.64
Price Target6.38 (139.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.77%
PT rev (3m)-4.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-394.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-16.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF 123.24
P/B 1.56
P/tB N/A
EV/EBITDA 39.18
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)0.02
OCFY0.81%
SpS21.4
BVpS1.7
TBVpS-2.79
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.75%
ROE -37.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.17%
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF N/A
Debt/EBITDA 27.23
Cap/Depr 102.7%
Cap/Sales 2.1%
Interest Coverage N/A
Cash Conversion 16.24%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.26
Altman-Z 2.5
F-Score4
WACC5.62%
ROIC/WACCN/A
Cap/Depr(3y)85.83%
Cap/Depr(5y)92.26%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-693.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.11%
EPS Next Y-2673.32%
EPS Next 2Y-158.2%
EPS Next 3Y55.13%
EPS Next 5YN/A
Revenue 1Y (TTM)2.79%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%-0.44%
Revenue Next Year-20.87%
Revenue Next 2Y2.37%
Revenue Next 3Y3.43%
Revenue Next 5Y6.63%
EBIT growth 1Y-267.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.31%
EBIT Next 3Y55.84%
EBIT Next 5Y57.12%
FCF growth 1Y-52.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y136.98%
OCF growth 3YN/A
OCF growth 5Y4.44%

OBIZ SA / ALBIZ.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OBIZ SA?

ChartMill assigns a fundamental rating of 2 / 10 to ALBIZ.PA.


What is the valuation status of OBIZ SA (ALBIZ.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to OBIZ SA (ALBIZ.PA). This can be considered as Overvalued.


How profitable is OBIZ SA (ALBIZ.PA) stock?

OBIZ SA (ALBIZ.PA) has a profitability rating of 1 / 10.


What is the financial health of OBIZ SA (ALBIZ.PA) stock?

The financial health rating of OBIZ SA (ALBIZ.PA) is 4 / 10.